Drugs / EC1456
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03011320 | Jan → Dec 2017 | ovarian cancer | Endocyte | Completed | No outcome recorded |
| Phase 1 | NCT01999738 | Oct 2013 → Dec 2017 | non-small cell lung carcinoma | Endocyte | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC1456 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03011320 ↗ |
| Modality | Small molecule | “EC1456 is small molecule drug conjugate” NCT01999738 ↗ |
| Route | Intravenous | “intravenous (IV) bolus dose” NCT03011320 ↗ |